Literature DB >> 16596623

Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.

Juan Liu1, Toshihito Suzuki, Tatsunori Seki, Takashi Namba, Atsushi Tanimura, Heii Arai.   

Abstract

Dysfunctional maturation of neural networks, particularly hippocampus-prefrontal networks, may be of particular interest in determining the pathophysiology of schizophrenia. Phencyclidine (PCP)-induced symptoms in humans appear to offer a more complete model of schizophrenia than do amphetamine-induced symptoms. This study investigated the effects of intermittent i.p. injections of PCP (7.5 mg/kg) on cell proliferation and survival of granule cells in the dentate gyrus of the rat brain using quantitative immunohistochemical techniques for 5-bromo-2'-deoxyuridine (BrdU)-positive cells. After repeated PCP injection for 14 days, mean scores for stereotyped behavior increased with the number of injections, while scores for ataxia and backpedaling as serotonergic behaviors gradually decreased. The number of BrdU-positive cells decreased by 23% in the subgranular zone of the dentate gyrus by 24 h after repeated injections. However, decreased levels of BrdU-positive cells returned to control levels within 1 week. Differentiation of newly formed cells was not influenced. Repeated PCP administration after BrdU injection did not exert any effects on survival of newly generated cells. These findings suggest that transient disturbances of cell proliferation in the dentate gyrus occur under PCP-related behavioral abnormalities. Whether disturbed cell proliferation would thus be closely implicated in the development of behavioral sensitization induced by PCP administration is unclear, but this would possibly result from adaptation to new pharmacological conditions under behavioral sensitization or stressful conditions of PCP-related abnormal behaviors. Further studies are required to elucidate the biological significance of hippocampal neurogenesis in the mechanisms underlying the development of cognitive dysfunctions and the psychosis of schizophrenia. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596623     DOI: 10.1002/syn.20275

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  16 in total

Review 1.  In vivo imaging of adult human hippocampal neurogenesis: progress, pitfalls and promise.

Authors:  N F Ho; J M Hooker; A Sahay; D J Holt; J L Roffman
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

Review 2.  Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders.

Authors:  R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

Review 3.  Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Authors:  Noah L Lazar; Richard W J Neufeld; Donald P Cain
Journal:  J Psychiatry Neurosci       Date:  2011-07       Impact factor: 6.186

Review 4.  New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.

Authors:  T J Bussey; A Holmes; L Lyon; A C Mar; K A L McAllister; J Nithianantharajah; C A Oomen; L M Saksida
Journal:  Neuropharmacology       Date:  2011-04-21       Impact factor: 5.250

5.  Risperidone and haloperidol promote survival of stem cells in the rat hippocampus.

Authors:  Gerburg Keilhoff; Gisela Grecksch; Hans-Gert Bernstein; Thomas Roskoden; Axel Becker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-05       Impact factor: 5.270

Review 6.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

Review 7.  Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation.

Authors:  Nathan A DeCarolis; Amelia J Eisch
Journal:  Neuropharmacology       Date:  2010-01-06       Impact factor: 5.250

8.  T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating.

Authors:  Tomonori Seo; Tomiki Sumiyoshi; Masahiko Tsunoda; Kodai Tanaka; Takashi Uehara; Tadasu Matsuoka; Hiroko Itoh; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2008-02-05       Impact factor: 4.530

Review 9.  Neurogenesis and schizophrenia: dividing neurons in a divided mind?

Authors:  Andreas Reif; Angelika Schmitt; Sabrina Fritzen; Klaus-Peter Lesch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-08       Impact factor: 5.760

10.  Irradiation in adulthood as a new model of schizophrenia.

Authors:  Yasuhide Iwata; Katsuaki Suzuki; Tomoyasu Wakuda; Norihito Seki; Ismail Thanseem; Hideo Matsuzaki; Takayoshi Mamiya; Takatoshi Ueki; Sumiko Mikawa; Takeshi Sasaki; Shiro Suda; Shigeyuki Yamamoto; Kenji J Tsuchiya; Genichi Sugihara; Kazuhiko Nakamura; Kohji Sato; Nori Takei; Kenji Hashimoto; Norio Mori
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.